default author photo

Andrew Bottomley

European Organisation for Research and Treatment of Cancer (EORTC)

SCHOLARLY PAPERS

3

DOWNLOADS

126

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Content Validity of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire QLQ-C30 for Use in Cancer

Number of pages: 20 Posted: 24 Aug 2022
Adelphi Values, Patient-Centered Outcomes, Adelphi Values, Patient-Centered Outcomes, University of Southampton, Martin Luther University of Halle-Wittenberg - Institute of Health & Nursing Science, University Hospital Regensburg - Center for Clinical Studies, Netherlands Comprehensive Cancer Organisation, University of Leeds, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale, Andrzej Frycz Modrzewski Kracow University, Netherlands Cancer Institute - Division of Psychosocial Research and Epidemiology, Adelphi Values, Patient-Centered Outcomes, Adelphi Values, Patient-Centered Outcomes, Swansea University, Adelphi Values, Patient-Centered Outcomes, University of Copenhagen, Faculty of Health and Medical Sciences, Department of Public Health, Adelphi Values, Patient-Centered Outcomes, University of Sussex - Brighton and Sussex Medical School and European Organisation for Research and Treatment of Cancer (EORTC)
Downloads 51 (1,052,702)
Citation 1

Abstract:

Loading...

Health Related Quality of Life, Patient Reported Outcomes, content validity, cancer, EORTC QLQ-C30, Qualitative interviews

2.

Minimally Important Differences for Interpreting ORTC QLQ-C30 Change Scores Over Time: A Synthesis Across 21 Clinical Trials Involving Nine Different Cancer Types

Number of pages: 29 Posted: 11 Mar 2023
European Organisation for Research and Treatment of Cancer (EORTC), European Organisation for Research and Treatment of Cancer (EORTC), University of Amsterdam - University Medical Center, Karolinska Institutet, University of Copenhagen, Faculty of Health and Medical Sciences, Department of Public Health, University Hospital Magdeburg, Adelphi Values, Patient-Centered Outcomes, University of Leeds, Leiden University - Leiden University Medical Center (LUMC), Medical University of Graz, University Medical Center Mainz, Maria Sklodowska-Curie National Research Institute of Oncology, Innsbruck Institute of Patient-centered Outcome Research (IIPCOR), University of Southampton, Princess Máxima Center for Pediatric Oncology, University Hospital Regensburg - Center for Clinical Studies, University of Amsterdam - Amsterdam University Medical Centers, Leiden University - Leiden University Medical Center (LUMC), The University of Sydney - School of Psychology and European Organisation for Research and Treatment of Cancer (EORTC)
Downloads 49 (1,074,648)

Abstract:

Loading...

Patient-reported outcomes (PRO), Health related quality of life (HRQoL), EORTC QLQ-C30, minimally important difference (MID), group-level change, cancer

3.

Health-Related Quality of Life Results from the Randomized Phase Ii Tavarec Trial on Temozolomide With or Without Bevacizumab in 1p/19q Intact First Recurrence Who Grade 2 and 3 Glioma (Eortc 26091)

Number of pages: 19 Posted: 12 May 2023
University of Amsterdam - Amsterdam University Medical Centers, European Organisation for Research and Treatment of Cancer (EORTC), European Organisation for Research and Treatment of Cancer (EORTC), Leiden University, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), KU Leuven, Sorbonne University, Utrecht University - Department of Medical Oncology, University of Amsterdam - Amsterdam University Medical Centers, Heidelberg University - University Hospital Heidelberg, University College Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, European Organisation for Research and Treatment of Cancer (EORTC), European Organisation for Research and Treatment of Cancer (EORTC), European Organisation for Research and Treatment of Cancer (EORTC), Erasmus MC - Brain Tumor Centre and Independent
Downloads 26 (1,372,601)

Abstract:

Loading...

Health-related quality of life, glioma, bevacizumab, temozolomide, EORTC, RCTs